Vaccines News
-
MSD signs pact with Indonesia's Bio Farma for HPV vaccine production
Vaccines | News | 0 Comment | 20 Dec, 2022
Bio Farma, Holding SOE Pharmacy – with its subsidiaries Kimia Farma and Indofarma, has signed a framework agreemen...Read more
-
China-based biotech startup's mRNA vaccine receives EUA in Laos
Vaccines | News | 0 Comment | 16 Dec, 2022
Chinese biotech startup Stemirna Therapeutics has received an Emergency Use Authorisation (EUA) from the FDA for ...Read more
-
Malaysia strives to develop children’s Hexavalent vaccine by 2023
Vaccines | News | 0 Comment | 14 Dec, 2022
Malaysia's Pharmaniaga LifeScience Sdn Bhd (PLS) and Pharmaniaga Berhad have signed a Research Collaboration Agreem...Read more
-
Moderna to expand Asia-Pacific presence with new Singapore subsidiary
Vaccines | News | 0 Comment | 12 Dec, 2022
Moderna, Inc., has announced its Singapore subsidiary with a new leadership announcement. Evelyn Pang has been ap...Read more
-
Takeda’s dengue tetravalent vaccine QDENGA receives approval in European Union
Vaccines | News | 0 Comment | 09 Dec, 2022
Japanese pharmaceutical firm Takeda has announced that the European Commission (EC) has granted marketing authorisation ...Read more
-
CEPI boosts 'Coronavirus X' vaccine search with expanded VBI Vaccines deal
Vaccines | News | 0 Comment | 08 Dec, 2022
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potentia...Read more
-
Vaxxas raises A$34 M to clinically advance needle-free vaccines
Vaccines | News | 0 Comment | 06 Dec, 2022
Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...Read more
-
Australia takes aim at next pandemic threat with new vaccine platform
Vaccines | News | 0 Comment | 28 Nov, 2022
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, is to put $5.7 million (AU$8.5 million) into the...Read more
-
XtalPi, CK Life Sciences announce AI-empowered tumour vaccine R&D in China
Vaccines | News | 0 Comment | 25 Nov, 2022
Chinese firm XtalPi is embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group....Read more
-
IVI, ST Pharm exchange MoU on clinical development of COVID-19 vaccine
Vaccines | News | 0 Comment | 25 Nov, 2022
The International Vaccine Institute (IVI) and ST Pharm have exchanged a Memorandum of Understanding (MoU) to establish a...Read more
-
SK bioscience announces KRW 3 Bn donation to IVI to support advancement of global vaccine R&D
Vaccines | News | 0 Comment | 18 Nov, 2022
SK bioscience, a leading vaccine manufacturer based in the Republic of Korea and a key partner of the International Vacc...Read more
-
Australia offers new nasal vaccine strategy to improve COVID-19 protection
Vaccines | News | 0 Comment | 17 Nov, 2022
Researchers from the Centenary Institute and the University of Sydney in Australia have developed a new nasal vaccinatio...Read more
-
Lemonex, IVI exchange MoU on joint vaccine development in Korea
Vaccines | News | 0 Comment | 14 Nov, 2022
The International Vaccine Institute (IVI), in South Korea, has signed a memorandum of understanding (MOU) with Lemonex, ...Read more
-
CSL signs $4 B agreement with Arcturus Therapeutics for self-amplifying mRNA vaccines
Vaccines | News | 0 Comment | 04 Nov, 2022
US-based Arcturus Therapeutics Holdings Inc. has announced a strategic collaboration with CSL Seqirus, a global vaccine ...Read more
-
Hilleman, MSD to develop thermostable next-gen Zaire ebolavirus vaccine
Vaccines | News | 0 Comment | 01 Nov, 2022
Singapore-based Hilleman Laboratories has announced collaberative efforts to develop a thermostable second-generati...Read more
-
CanSino Biologics rolls out inhaled vaccine Convidecia Air in Shanghai
Vaccines | News | 0 Comment | 01 Nov, 2022
CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...Read more
-
Vaccines | Analysis | By Hithaishi C Bhaskar | 0 Comment | 31 Oct, 2022
Globally, mass vaccination practices and procedures were not pleasant experiences for everyone. Different age groups and...Read more
-
SK bioscience and Hilleman to co-develop novel vaccine platforms
Vaccines | News | 0 Comment | 27 Oct, 2022
South Korea's SK bioscience has entered a strategic partnership with Singapore based Hilleman Laboratories to co-develop...Read more
